Trials / Completed
CompletedNCT02755376
Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell
A Randomized, Single Center, Investigator Initiated Clinical Trial to Evaluate Enhancement of Healing Between Bone Tunnel and Graft in Anterior Cruciate Ligament (ACL) Injury Using Human Umbilical Cord Blood Derived Mesenchymal Stem Cell
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Purpose:Development of novel strategy for treatment of anterior cruciate ligament (ACL) injury using stem cell.
Detailed description
1. Purpose: Development of novel strategy for treatment of anterior cruciate ligament (ACL) injury using stem cell. 2. Subject: Anterior cruciate ligament (ACL) injury 30 patients * ACL reconstruction: 10 * ACL reconstruction + Human cord blood derived mesenchymal stem cells and hyaluronic acid (Cartistem (TM)): 10 * ACL reconstruction + hyaluronic acid: 10 3. Hypothesis: Human Cord blood derived mesenchymal stem cells can enhance healing between bone tunnel and graft in ACL reconstruction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Cartistem(TM) | ACL reconstruction and injection of Cartstem(TM), human cord blood derived mesenchymal stem cell under arthroscopy. |
| BIOLOGICAL | hyaluronic acid | ACL reconstruction and injection of hyaluronic acid under arthroscopy. |
| PROCEDURE | ACL reconstruction only | ACL reconstruction only without any injection under arthroscopy |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2016-04-28
- Completion
- 2018-12-01
- First posted
- 2016-04-28
- Last updated
- 2019-04-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02755376. Inclusion in this directory is not an endorsement.